These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26087187)

  • 1. MIF, secreted by human hepatic sinusoidal endothelial cells, promotes chemotaxis and outgrowth of colorectal cancer in liver prometastasis.
    Hu CT; Guo LL; Feng N; Zhang L; Zhou N; Ma LL; Shen L; Tong GH; Yan QW; Zhu SJ; Bian XW; Lai MD; Deng YJ; Ding YQ
    Oncotarget; 2015 Sep; 6(26):22410-23. PubMed ID: 26087187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor promotes colorectal cancer.
    He XX; Chen K; Yang J; Li XY; Gan HY; Liu CY; Coleman TR; Al-Abed Y
    Mol Med; 2009; 15(1-2):1-10. PubMed ID: 19009023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
    Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
    World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor siRNA inhibits hepatic metastases of colorectal cancer cells.
    Wu LH; Xia HH; Ma WQ; Zhong HJ; Xu HX; Wang YM; Yang RJ; Wang LJ; Chen Y; Li L; He XX
    Front Biosci (Landmark Ed); 2017 Mar; 22(8):1365-1378. PubMed ID: 28199208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.
    Dai X; Ge J; Wang X; Qian X; Zhang C; Li X
    Oncol Rep; 2013 Jan; 29(1):155-60. PubMed ID: 23076549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells.
    Cheon SK; Kim HP; Park YL; Jang JE; Lim Y; Song SH; Han SW; Kim TY
    Mol Oncol; 2018 Aug; 12(8):1398-1409. PubMed ID: 29896883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis.
    Chou CK; Fan CC; Lin PS; Liao PY; Tung JC; Hsieh CH; Hung MC; Chen CH; Chang WC
    Oncotarget; 2016 May; 7(18):25742-54. PubMed ID: 27013588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor has a permissive role in concanavalin A-induced cell death of human hepatoma cells through autophagy.
    Lai YC; Chuang YC; Chang CP; Yeh TM
    Cell Death Dis; 2015 Dec; 6(12):e2008. PubMed ID: 26633714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage Migration Inhibitory Factor Promotes the Interaction between the Tumor, Macrophages, and T Cells to Regulate the Progression of Chemically Induced Colitis-Associated Colorectal Cancer.
    Pacheco-Fernández T; Juárez-Avelar I; Illescas O; Terrazas LI; Hernández-Pando R; Pérez-Plasencia C; Gutiérrez-Cirlos EB; Ávila-Moreno F; Chirino YI; Reyes JL; Maldonado V; Rodriguez-Sosa M
    Mediators Inflamm; 2019; 2019():2056085. PubMed ID: 31360118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell-derived fibronectin extra domain A promotes colorectal cancer metastasis via inducing epithelial-mesenchymal transition.
    Ou J; Peng Y; Deng J; Miao H; Zhou J; Zha L; Zhou R; Yu L; Shi H; Liang H
    Carcinogenesis; 2014 Jul; 35(7):1661-70. PubMed ID: 24743511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers.
    Legendre H; Decaestecker C; Nagy N; Hendlisz A; Schüring MP; Salmon I; Gabius HJ; Pector JC; Kiss R
    Mod Pathol; 2003 May; 16(5):491-504. PubMed ID: 12748256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
    Dumitru CA; Gholaman H; Trellakis S; Bruderek K; Dominas N; Gu X; Bankfalvi A; Whiteside TL; Lang S; Brandau S
    Int J Cancer; 2011 Aug; 129(4):859-69. PubMed ID: 21328346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
    Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
    Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer.
    Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J
    Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived MIF: a novel platelet chemokine with distinct recruitment properties.
    Wirtz TH; Tillmann S; Strüßmann T; Kraemer S; Heemskerk JW; Grottke O; Gawaz M; von Hundelshausen P; Bernhagen J
    Atherosclerosis; 2015 Mar; 239(1):1-10. PubMed ID: 25561410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.